Lupin's Pithampur manufacturing unit produces both APIs (Active Pharmaceutical Ingredients) and finished products ...

Lupin’s Pithampur Unit-1 facility gets EIR from US FDA with VAI classification: Our Bureau, Mumbai Thursday, January 9, 2025, 12:30 Hrs [IST] Global pharma major Lupin Limited ( ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

of Janssen Pharmaceuticals, Inc. This product will be manufactured at Lupin’s Pithampur facility in India. USFDA gives nod to Lupin’s generic formulation to treat high uric acid Rivaroxaban ...

Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Thursday, January 9, 2025, 17:20 Hrs [IST] Global pharma major Lupin Limited ...

30 Sep 2024 The Mumbai-based pharmaceutical company announced that the US FDA conducted an inspection of Lupin’s Pithampur Unit-1 API and finished product manufacturing facility from September ...

Here’s a quick look at stocks likely to be in focus in today's trade. Tata Motors (Jaguar Land Rover): Jaguar Land Rover (JLR), a subsidiary of Tata Motors, showcased a mixed performance in Q3 FY25.

Pharma major Lupin has acquired Huminsulin brand in India from Eli Lilly, in an effort to enhance its diabetes portfolio, the company said in an exchange filing on December 30. Lupin had been ...

Lupin: Pharmaceutical company Lupin received an Establishment Inspection Report (EIR) from the US FDA for its Pithampur Unit-1 facility, which manufactures APIs and finished products. The EIR ...